Jul 11, 2025
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - Nippon India Pharma Fund (IDCW) | 0.21 | 0.8 | 11.79 | 24.41 |
| Benchmark - S&P BSE Healthcare | 14.73 | 38.57 | 53.75 | 13.45 |
| Category Average - BEST EQUITY PERFORMERS | 0.35 | 4.7 | 1.9 | 22.19 |
| Category Rank | 4/10 | 9/10 | 6/10 | 7/10 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund - Regular (G) | 38.7500 | 1.00 | 13.45 | 23.16 | 22.27 | 2,785.12 | 0.00 | 5,000.00 | invest |
| Mirae Asset Healthcare Fund - Regular (IDCW) | 24.8770 | 1.00 | 13.45 | 23.14 | 22.26 | 2,785.12 | 0.00 | 5,000.00 | invest |
| HDFC Pharma and Healthcare Fund - Regular (IDCW) | 17.1780 | 0.83 | 24.88 | 0.00 | 0.00 | 1,786.18 | 2.02 | 100.00 | invest |
| HDFC Pharma and Healthcare Fund - Regular (G) | 17.1780 | 0.83 | 24.88 | 0.00 | 0.00 | 1,786.18 | 2.02 | 100.00 | invest |
| HDFC Defence Fund - Regular (G) | 24.7460 | -1.75 | -0.28 | 0.00 | 0.00 | 7,055.48 | 1.77 | 100.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | May 31, 2025 | 1,049.57 | 12.57 | -8.44 |
|
| Equity-Divi`s Lab. | May 31, 2025 | 792.65 | 9.49 | 0.26 |
|
| Equity-Lupin | May 31, 2025 | 486.29 | 5.82 | -6.58 |
|
| Equity-Cipla | May 31, 2025 | 469.02 | 5.62 | -5.44 |
|
| Equity-Dr Reddy`s Labs | May 31, 2025 | 458.21 | 5.49 | 5.68 |
|
| Equity-Apollo Hospitals | May 31, 2025 | 446.40 | 5.34 | -1.38 |
|
| Equity-Medplus Health | May 31, 2025 | 350.54 | 4.20 | 19.88 |
|
| Equity-Glaxosmi. Pharma | May 31, 2025 | 311.30 | 3.73 | 3.77 |
|
| Equity-Vijaya Diagnost. | May 31, 2025 | 270.78 | 3.24 | -4.42 |
|
| Equity-Narayana Hrudaya | May 31, 2025 | 245.36 | 2.94 | -2.28 |
|
Nippon India Mutual Fund has announced 14 July 2025 as the record date for ...
Nippon India Mutual Fund has announced change in fund manager under the fol...
Nippon India Mutual Fund has announced change in scheme name under the foll...
Nippon India Mutual Fund has announced 13 June 2025 as the record date for ...
Nippon India Mutual Fund has announced 14 May 2025 as the record date for d...
Nippon India Mutual Fund has announced change in scheme name under the foll...
| AMC Name | : | Nippon India Mutual Fund |
| Fund Name | : | Nippon India Pharma Fund (IDCW) |
| Contact Persone | : | Sailesh Raj Bhan |
| Registered Address | : | 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013. |
| Telephone No | : | 022-68087000/1860260111 |
| Fax No. | : | 022-68087097 |
| : | customercare:nipponindiaim.in | |
| Website | : | mf.nipponindiaim.com |
